Profil
Justin Xiang is the founder and Chief Investment Officer at Syno Partners LLC, which he founded in 2015.
He is currently a Director at Seaport Diagnostics, Inc. Dr. Xiang was also a Director at LungLife AI, Inc.
Postes actifs de Justin Xiang
| Sociétés | Poste | Début |
|---|---|---|
Seaport Diagnostics, Inc.
Seaport Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a diagnostic center for testing | Directeur/Membre du Conseil | - |
Syno Partners LLC
Syno Partners LLC Investment ManagersFinance Syno Partners invests in companies located in the United States. The firm focuses on biotech, life science and healthcare sector. It participates in early stage capital transactions. | Fondateur | 01/01/2015 |
Anciens postes connus de Justin Xiang
| Sociétés | Poste | Fin |
|---|---|---|
| LUNGLIFE AI, INC. | Directeur/Membre du Conseil | 01/07/2021 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
LungLife AI, Inc.
LungLife AI, Inc. Medical SpecialtiesHealth Technology Develops early detection solutions for lung cancer | Health Technology |
Seaport Diagnostics, Inc.
Seaport Diagnostics, Inc. Medical/Nursing ServicesHealth Services Operates as a diagnostic center for testing | Health Services |
Syno Partners LLC
Syno Partners LLC Investment ManagersFinance Syno Partners invests in companies located in the United States. The firm focuses on biotech, life science and healthcare sector. It participates in early stage capital transactions. | Finance |
















